About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5445966
Allelic
Composition
Raf1tm2.1Ara/Raf1tm2.1Ara
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6NCr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Raf1tm2.1Ara mutation (0 available); any Raf1 mutation (85 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• most mice with severe growth defects die shortly after weaning (J:189143)
• remaining mice with severe growth defects die between 4 and 8 months (J:189143)
• however, mice with normal growth exhibit normal survival (J:189143)
• most mice with severe growth defects die shortly after weaning (J:189143)
• remaining mice with severe growth defects die between 4 and 8 months (J:189143)
• however, mice with normal growth exhibit normal survival (J:189143)

cardiovascular system
• neonatal cardiomyocytes exhibit increased surface area compared with wild-type cells (J:189143)
• neonatal cardiomyocytes exhibit increased surface area compared with wild-type cells (J:189143)
• in mice with normal growth (J:189143)
• in mice with normal growth (J:189143)
• in mice with normal growth (J:189143)
• in mice with normal growth (J:189143)
• concentric cardiac hypertrophy with enhanced cardiac function (J:189143)
• severity of cardiac phenotype correlates with Mek/Erk activation (J:189143)
• concentric cardiac hypertrophy with enhanced cardiac function (J:189143)
• severity of cardiac phenotype correlates with Mek/Erk activation (J:189143)
• increased left ventricular diastolic posterior wall thickness (J:189143)
• reduced left ventricular internal end-systolic dimension (J:189143)
• however, left ventricular internal end-diastolic dimension is normal (J:189143)
• increased left ventricular diastolic posterior wall thickness (J:189143)
• reduced left ventricular internal end-systolic dimension (J:189143)
• however, left ventricular internal end-diastolic dimension is normal (J:189143)
• increased fractional shortening and ejection fraction (J:189143)
• increased fractional shortening and ejection fraction (J:189143)

growth/size/body
• in one-third of mice (J:189143)
• in one-third of mice (J:189143)
• in one-third of mice (J:189143)
• in one-third of mice (J:189143)

craniofacial
• mice with severe growth defects exhibit reduced skull length, slight decrease in width and triangular facial appearance compared with wild-type mice (J:189143)
• however, mice with normal growth exhibit normal facial morphology (J:189143)
• mice with severe growth defects exhibit reduced skull length, slight decrease in width and triangular facial appearance compared with wild-type mice (J:189143)
• however, mice with normal growth exhibit normal facial morphology (J:189143)
• in mice with severe growth defects (J:189143)
• however, mice with normal growth exhibit normal facial morphology (J:189143)
• in mice with severe growth defects (J:189143)
• however, mice with normal growth exhibit normal facial morphology (J:189143)

behavior/neurological
• in surviving mice with severe growth defects (J:189143)
• in surviving mice with severe growth defects (J:189143)
• in surviving mice with severe growth defects (J:189143)
• in surviving mice with severe growth defects (J:189143)

integument
• in surviving mice with severe growth defects (J:189143)
• in surviving mice with severe growth defects (J:189143)

hematopoietic system
N
• mice do not exhibit splenomegaly nor overt hematological defects (J:189143)
• mice do not exhibit splenomegaly nor overt hematological defects (J:189143)

muscle
• neonatal cardiomyocytes exhibit increased surface area compared with wild-type cells (J:189143)
• neonatal cardiomyocytes exhibit increased surface area compared with wild-type cells (J:189143)
• increased fractional shortening and ejection fraction (J:189143)
• increased fractional shortening and ejection fraction (J:189143)

skeleton
• mice with severe growth defects exhibit reduced skull length, slight decrease in width and triangular facial appearance compared with wild-type mice (J:189143)
• however, mice with normal growth exhibit normal facial morphology (J:189143)
• mice with severe growth defects exhibit reduced skull length, slight decrease in width and triangular facial appearance compared with wild-type mice (J:189143)
• however, mice with normal growth exhibit normal facial morphology (J:189143)
• in mice with severe growth defects (J:189143)
• however, mice with normal growth exhibit normal facial morphology (J:189143)
• in mice with severe growth defects (J:189143)
• however, mice with normal growth exhibit normal facial morphology (J:189143)

Mouse Models of Human Disease
OMIM ID Ref(s)
Noonan Syndrome 5; NS5 611553 J:189143


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
02/02/2016
MGI 6.02
The Jackson Laboratory